You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Repurposing existing drugs for new uses: a cohort study of the frequency of FDA-granted new indication exclusivities since 1997
|
|---|---|
| Published in |
Journal of Pharmaceutical Policy and Practice, January 2021
|
| DOI | 10.1186/s40545-020-00282-8 |
| Pubmed ID | |
| Authors |
Babak Sahragardjoonegani, Reed F. Beall, Aaron S. Kesselheim, Aidan Hollis |
X Demographics
The data shown below were collected from the profiles of 24 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 13% |
| Canada | 3 | 13% |
| United Kingdom | 2 | 8% |
| Egypt | 1 | 4% |
| Japan | 1 | 4% |
| Sweden | 1 | 4% |
| New Zealand | 1 | 4% |
| Unknown | 12 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 13 | 54% |
| Scientists | 8 | 33% |
| Practitioners (doctors, other healthcare professionals) | 2 | 8% |
| Science communicators (journalists, bloggers, editors) | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 42 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 8 | 19% |
| Student > Master | 5 | 12% |
| Student > Bachelor | 3 | 7% |
| Student > Ph. D. Student | 3 | 7% |
| Professor | 2 | 5% |
| Other | 5 | 12% |
| Unknown | 16 | 38% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 4 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 7% |
| Medicine and Dentistry | 3 | 7% |
| Chemistry | 3 | 7% |
| Agricultural and Biological Sciences | 3 | 7% |
| Other | 9 | 21% |
| Unknown | 17 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 225. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 April 2023.
All research outputs
#164,182
of 24,846,849 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#4
of 476 outputs
Outputs of similar age
#4,701
of 516,098 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#1
of 20 outputs
Altmetric has tracked 24,846,849 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 476 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.2. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 516,098 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.